Harmony Biosciences Holdings (HRMY) EBT Margin (2020 - 2025)
Historic EBT Margin for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Q3 2025 value amounting to 28.18%.
- Harmony Biosciences Holdings' EBT Margin fell 52300.0% to 28.18% in Q3 2025 from the same period last year, while for Sep 2025 it was 27.9%, marking a year-over-year increase of 21900.0%. This contributed to the annual value of 26.84% for FY2024, which is 29600.0% down from last year.
- According to the latest figures from Q3 2025, Harmony Biosciences Holdings' EBT Margin is 28.18%, which was down 52300.0% from 24.76% recorded in Q2 2025.
- Harmony Biosciences Holdings' 5-year EBT Margin high stood at 34.37% for Q4 2022, and its period low was 13.03% during Q3 2021.
- For the 5-year period, Harmony Biosciences Holdings' EBT Margin averaged around 23.98%, with its median value being 27.41% (2022).
- In the last 5 years, Harmony Biosciences Holdings' EBT Margin surged by 2070300bps in 2021 and then crashed by -203000bps in 2024.
- Over the past 5 years, Harmony Biosciences Holdings' EBT Margin (Quarter) stood at 26.83% in 2021, then increased by 28bps to 34.37% in 2022, then tumbled by -31bps to 23.57% in 2023, then rose by 18bps to 27.9% in 2024, then rose by 1bps to 28.18% in 2025.
- Its EBT Margin was 28.18% in Q3 2025, compared to 24.76% in Q2 2025 and 30.95% in Q1 2025.